Neferine reduces the survival, movement, and infiltration of lung cancer cells in laboratory conditions by promoting pyroptosis through the suppression of TGF‐β, as well as by suppressing EMT and controlling the expression of macrophage‐stimulating1 (MST1). This evidence concerns the gene TGFB1 and lung carcinoma.